Lilly drug fails to improve survival in breast cancer trial
(Reuters) - Eli Lilly and Co will not seek approval for one of its most promising experimental drugs for treating breast cancer after it failed in a l...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/4cuwPrqPxjA/story01.htm
No comments:
Post a Comment